1,6 - substituted (3R,6R) -3- (2,3-dihydro-1H-inden-2-yl)-2,5-piperazi nedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis

Details for Australian Patent Application No. 2005317886 (hide)

Owner Glaxo Group Limited

Inventors Liddle, John; Philp, Joanne; Smith, Ian Edward David; Zhang, Jing; Peace, Simon; Terrell, Lamont Roscoe; Leach, Colin Andrew

Agent Davies Collison Cave

Pub. Number AU-A-2005317886

PCT Pub. Number WO2006/067462

Priority 0428235.6 23.12.04 GB

Filing date 22 December 2005

Wipo publication date 29 June 2006

International Classifications

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/067462 Priority application(s): WO2006/067462

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005317890-Pyrazines and pyridines and derivatives thereof as therapeutic compounds

2005317883-Clamp head